University of Côte d'Azur / Université Côte d'Azur

TARGIT-IORT During Lumpectomy for Breast Cancer Reply (2021) Polgar C, Strnad V, Hannoun-Levi JM, Major T, Takacsi-Nagy Z, Fodor J Journal article, Editorial In regard to “The Italian association of radiotherapy and oncology recommendation for breast tumor recurrence: grades of recommendation, assessment, development and evaluation criteria” (2021) Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V Journal article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article HeMoG: A White-Box Model to Unveil the Connection Between Saliency Information and Human Head Motion in Virtual Reality (2021) Rondon MFR, Zanca D, Melacci S, Gori M, Sassatelli L Conference contribution Corrigendum to: More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. (2021) Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, et al. Journal article, Erratum Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms (2021) Gerkin RC, Ohla K, Veldhuizen MG, Joseph PV, Kelly CE, Bakke AJ, Steele KE, et al. Journal article Dynamic expression of NR2F1 and SOX2 in developing and adult human cortex: comparison with cortical malformations (2021) Foglio B, Rossini L, Garbelli R, Regondi MC, Mercurio S, Bertacchi M, Avagliano L, et al. Journal article Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database (2021) Hannoun-Levi JM, Gal J, Van Limbergen E, Chand ME, Schiappa R, Smanyko V, Kauer-Domer D, et al. Journal article A global benchmark of algorithms for segmenting the left atrium from late gadolinium-enhanced cardiac magnetic resonance imaging (2021) Xiong Z, Xia Q, Hu Z, Huang N, Bian C, Zheng Y, Vesal S, et al. Journal article Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial (2020) Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al. Journal article